High levels of LINE-1 transposable elements expressed in Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma

被引:2
|
作者
Ahuja, Anuj [1 ]
Journo, Guy [1 ]
Eitan, Ron [1 ]
Rubin, Eitan [2 ]
Shamay, Meir [1 ]
机构
[1] Bar Ilan Univ, Azrieli Fac Med, Daniella Lee Casper Lab Viral Oncol, Safed, Israel
[2] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel
基金
以色列科学基金会;
关键词
IMMUNODEFICIENCY-VIRUS-INFECTION; ENDOGENOUS RETROVIRUS HERV-K18; ENCODED REVERSE-TRANSCRIPTASE; GENE-EXPRESSION; CELL-PROLIFERATION; DNA; RETROTRANSPOSITION; DIFFERENTIATION; HYPOMETHYLATION; IDENTIFICATION;
D O I
10.1038/s41388-020-01549-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8) is a gamma herpesvirus associated with several human malignancies. Transposable elements (TEs) are ubiquitous in eukaryotic genomes, occupying about 45% of the human genome. TEs have been linked with a variety of disorders and malignancies, though the precise nature of their contribution to many of them has yet to be elucidated. Global transcriptome analysis for differentially expressed TEs in KSHV-associated primary effusion lymphoma (PEL) cells (BCBL1 and BC3) revealed large number of differentially expressed TEs. These differentially expressed TEs include LTR transposons, long interspersed nuclear elements (LINEs), and short interspersed nuclear elements (SINEs). Further analysis of LINE-1 (L1) elements revealed expression upregulation, hypo-methylation, and transition into open chromatin in PEL. In agreement with high L1 expression, PEL cells express ORF1 protein and possess high reverse transcriptase (RT)-activity. Interestingly, inhibition of this RT-activity suppressed PEL cell growth. Collectively, we identified high expression of TEs, and specifically of L1 as a critical component in the proliferation of PEL cells. This observation is relevant for the treatment of KSHV-associated malignancies since they often develop in AIDS patients that are treated with RT inhibitors with potent inhibition for both HIV and L1 RT activity.
引用
收藏
页码:536 / 550
页数:15
相关论文
共 50 条
  • [11] Primary effusion lymphoma: A distinct clinico-pathologic entity associated with the Kaposi's sarcoma-associated herpesvirus
    Cesarman, E
    Nador, RG
    Chadburn, A
    Dawson, DB
    Ansari, MQ
    Said, J
    Knowles, DM
    LABORATORY INVESTIGATION, 1996, 74 (01) : 628 - 628
  • [12] Kaposi's sarcoma-associated herpesvirus (KSHV): A new viral pathogen associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
    Said, J
    WESTERN JOURNAL OF MEDICINE, 1997, 167 (01): : 37 - 38
  • [13] Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
    Gao, SJ
    Kingsley, L
    Hoover, DR
    Spira, TJ
    Rinaldo, CR
    Saah, A
    Phair, J
    Detels, R
    Parry, P
    Chang, Y
    Moore, PS
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (04): : 233 - 241
  • [14] Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: Ultrastructural demonstration of herpesvirus in lymphoma cells
    Said, JW
    Chien, K
    Takeuchi, S
    Tasaka, T
    Asou, H
    Cho, SK
    deVos, S
    Cesarman, E
    Knowles, DM
    Koeffler, HP
    BLOOD, 1996, 87 (12) : 4937 - 4943
  • [15] Oxidative Stress Induces Reactivation of Kaposi's Sarcoma-Associated Herpesvirus and Death of Primary Effusion Lymphoma Cells
    Li, Xudong
    Feng, Jiaying
    Sun, Ren
    JOURNAL OF VIROLOGY, 2011, 85 (02) : 715 - 724
  • [16] Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a gene expression profile
    Jenner, RG
    Maillard, K
    Cattini, N
    Weiss, RA
    Boshoff, C
    Wooster, R
    Kellam, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) : 10399 - 10404
  • [17] Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
    Peter D Burbelo
    Alexandra T Issa
    Kathryn H Ching
    Kathleen M Wyvill
    Richard F Little
    Michael J Iadarola
    Joseph A Kovacs
    Robert Yarchoan
    Infectious Agents and Cancer, 5 (Suppl 1)
  • [18] Epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease
    Sullivan, Ryan J.
    Pantanowitz, Liron
    Casper, Corey
    Stebbing, Justin
    Dezube, Bruce J.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (09) : 1209 - 1215
  • [20] ROLE OF PHOSPHOLIPASE D2 SIGNALING IN KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS (KSHV)-ASSOCIATED PRIMARY EFFUSION LYMPHOMA
    Van den Avont, Alexander
    Sharma-Walia, Neelam
    Dobre, Adina
    Powrozek, Olivia
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (07) : 1605 - 1606